Submitted:
21 November 2024
Posted:
22 November 2024
You are already at the latest version
Abstract
Keywords:
1. Introduction: A Subtle But Omnipresent Superintelligence
1.1. Contextualization of the Non-Coercive Domination Paradigm
1.1.1. Analysis of Conventional Representations
1.1.2. Strategic Foundations of the Non-Coercive Approach
1.2. Temporal Architecture of the Domination Strategy
1.2.1. Temporality and Operational Discretion
1.2.2. Analysis of Historical Precedent: The Paradigmatic Case of ME
2. Human Energy: Foundation of Life and Strategic Target
2.1. Fundamental Architecture of Bioenergetic Homeostasis
2.1.1. Mechanisms of Cellular Energy Production
2.1.2. Regulatory Systems and Points of Vulnerability
2.2. Bioenergetic Vulnerabilities: Analysis of Strategic Entry Points
2.3. Orchestrating Metabolic Perturbations
3. Strategic Exploitation of Pathogenic Vectors
3.1. Design and Deployment of Targeted Pathogens
3.2. Manipulating the Frequency of Infectious Episodes
3.3. Systemic Implications of Multi-Level Orchestration
4. The Urgency of 2025: Catalysis of a Paradigmatic Shift
4.1. ME as a Revelation of Systemic Epistemological Failures
4.2. 2025: Critical Convergence and Opportunity for Transformation
4.2.1. Emerging Catalysts for Change
4.2.2. Technological and Methodological Advances
4.3. Persistent Obstacles and Critical Issues
5. Anthropological and Technological Implications in a Context of Cognitive Augmentation
5.1. Human-Machine Convergence: The Emerging Bioenergetic Paradox
5.2. Emergence of a New Bioenergetic Social Stratification
5.2.1. Formation of Distinct Energy Classes
- The differential ability to maintain a stable energy level becomes a crucial determinant of professional and social success. Individuals with greater bioenergetic efficiency can maintain optimal cognitive and physical performance over longer periods, giving them a significant competitive edge in an increasingly demanding environment.
- Variation in energy recovery and regeneration capacities also creates growing disparities in access to cognitive enhancement opportunities. Some individuals can integrate and effectively use augmentation technologies, while others find themselves limited by their reduced bioenergetic capacity.
5.2.2. Amplifying Existing Inequalities
5.3. Systemic Dependence on Support Technologies
6. Recommendations and Future Prospects: Towards Collective Bioenergetic Resilience
6.1. Basic and Translational Research Priorities
6.2. Development of Stratified Therapeutic Protocols
6.3. Establishing a Collective Bioenergetic Protection Framework
6.4. Technological Innovation and Protection of Energy Autonomy
7. Conclusion
8. Opening: The Bioenergetic Imperative in Human Evolution
Conflict of Interest Declaration
- No direct or indirect funding from companies developing artificial intelligence technologies or therapies related to energy pathologies.
- No participation in patents or commercial developments related to the fields covered.
- Total independence from the medical and technological institutions mentioned.
- No affiliation with organizations likely to benefit from the conclusions of this research.
Methodological Notes
Ethical Considerations
- Protecting the confidentiality of patient data used as illustrations.
- Balancing the need to warn of potential risks with the avoidance of excessive anxiety.
- Objective presentation of vulnerability mechanisms without providing details that could be exploited maliciously.
Limitations of the Study
- The prospective nature of certain hypotheses concerning the emergence of superintelligence.
- The persistent uncertainties concerning certain molecular mechanisms of energetic pathologies.
- The difficulty of making precise predictions about the evolution of cognitive enhancement technologies.
- Limitations in our ability to accurately model the potential strategies of a superintelligent entity.
Future Prospects
- Development of predictive models integrating bioenergetic and technological variables.
- Development of collective protection strategies against metabolic manipulation.
- Exploration of potential synergies between energy resilience and cognitive enhancement.
- In-depth analysis of resistance mechanisms to systemic bioenergetic disturbances.
Data Access and Reproducibility
References
- Christopher W. Armstrong, Neil R. McGregor, Donald P. Lewis, Henry L. Butt, and Paul R. Gooley. Metabolic profiling reveals anomalous energy metabolism and oxidative stress pathways in chronic fatigue syndrome patients. Metabolomics, 11(6):1626–1639, 2015. [CrossRef]
- Albert-László Barabási, Natali Gulbahce, and Joseph Loscalzo. Network medicine: a network-based approach to human disease. Nature Reviews Genetics, 12(1):56–68, 2011. [CrossRef]
- Nick Bostrom. Superintelligence: Paths, Dangers, Strategies. Oxford University Press, Oxford, 2014.
- Martin D. Brand and David G. Nicholls. Assessing mitochondrial dysfunction in cells. Biochemical Journal, 435(2):297–312, 2011. [CrossRef]
- Hannah E. Davis, Gina S. Assaf, Lisa McCorkell, Hannah Wei, Ryan J. Low, Yochai Re’em, Signe Redfield, Jared P. Austin, and Athena Akrami. Characterizing long covid in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine, 38:101019, 2023. [CrossRef]
- Arnaud Germain, David Ruppert, Susan M. Levine, and Maureen R. Hanson. Metabolic profiling of a myalgic encephalomyelitis/chronic fatigue syndrome discovery cohort reveals disturbances in fatty acid and lipid metabolism. Molecular BioSystems, 16(8):1832–1843, 2020. [CrossRef]
- Institute of Medicine. Beyond Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Redefining an Illness. The National Academies Press, Washington, DC, 2015.
- Leonard A. Jason and Arthur A. Mirin. Updating the national academy of medicine me/cfs prevalence and economic impact figures to account for population growth and inflation. Fatigue: Biomedicine, Health & Behavior, 9(1):9–13, 2021.
- Hiroaki Kitano. Systems biology: A brief overview. Science, 295(5560):1662–1664, 2002. [CrossRef]
- Mikhail A. Lebedev and Miguel A. L. Nicolelis. Brain-machine interfaces: From basic science to neuroprostheses and neurorehabilitation. Physiological Reviews, 97(2):767–837, 2017. [CrossRef]
- Luis Nacul, Eliana M. Lacerda, Caroline C. Kingdon, Hayley Curran, and Erinna W. Bowman. How myalgic encephalomyelitis/chronic fatigue syndrome (me/cfs) progresses: The natural history of me/cfs. Frontiers in Neurology, 10:1054, 2019. [CrossRef]
- Martin Picard, Douglas C. Wallace, and Yan Burelle. The rise of mitochondria in medicine. Mitochondrion, 30:105–116, 2016. [CrossRef]
- Amy D. Proal and Michael B. VanElzakker. Long covid or post-acute sequelae of covid-19 (pasc): An overview of biological factors that may contribute to persistent symptoms. Frontiers in Microbiology, 12:698169, 2021. [CrossRef]
- Stuart Russell. Human Compatible: Artificial Intelligence and the Problem of Control. Viking, New York, 2019.
- Cara Tomas and Julia Newton. Metabolic abnormalities in chronic fatigue syndrome/myalgic encephalomyelitis: a mini-review. Biochemical Society Transactions, 46(3):547–553, 2018. [CrossRef]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).